Therefore, we chose MLN4924, a small-molecule inhibitor of NEDD8-activating enzymes that can block neddylation of all cullins and induce CRL substrate accumulation, as an adjuvant therapy for use with 10-HCPT against HNSCC. This evidence concerns the gene IL31RA and head and neck squamous cell carcinoma.